Lecciones y desafíos del uso de los grupos relacionados por el diagnóstico en Chile / Using diagnosis-related groups in Chile: lessons and challenges / Lições e desafios do uso de grupos de diagnósticos relacionados no Chile

RESUMEN Objetivo. Analizar la implementación de los grupos relacionados por el diagnóstico (GRD) en Chile con miras a optimizar la distribución de los recursos públicos. Método. Se utilizó un análisis narrativo cronológico de los principales hitos, complementado por simulaciones de aplicación de los GRD mediante competencia emulada y análisis de conglomerados para fines evaluativos. Resultados. En el año 2001 se introdujeron los GRD en Chile, en un contexto académico. El Fondo Nacional de Salud (FONASA) comenzó a utilizarlos en el sector privado y, con un piloto, en el sector público en el 2015. Tras casi dos décadas de avances, en el 2020 se instaló el programa GRD como mecanismo de pago para los hospitales públicos desde el FONASA. Sin embargo, la pandemia de COVID-19 enlenteció su desarrollo. En el 2022 se retomó la aplicación y, tras evaluar el programa, se evidenció que los conglomerados de hospitales predefinidos para el pago diferenciado por GRD no lograron diferenciar grupos homogéneos. En el 2023 se reformó el programa y se aumentaron los recursos financieros, se definió un solo conglomerado y una tasa base, y se reconoció una mayor complejidad hospitalaria que la de años previos. Además, se agregaron tres hospitales al programa, con un total de 68. Conclusiones. La experiencia muestra que es posible dar continuidad a una política pública de financiamiento de la salud para lograr una mayor eficiencia y equidad en el sistema de salud, sobre la base de la existencia de instituciones robustas que persistan en su desarrollo y mejoramiento continuo.

ABSTRACT Objective. Analyze the implementation of diagnosis-related groups (DRGs) in Chile with a view to optimizing the distribution of public resources. Methods. A chronological narrative analysis of the main milestones was complemented by simulated application of DRGs through emulated competition and cluster analysis for evaluative purposes. Results. In 2001, DRGs were introduced in Chile in an academic context. The National Health Fund (FONASA) began using DRGs in the private sector. A public sector pilot was launched in 2015. After nearly two decades of progress, in 2020 FONASA established the DRG program as a payment mechanism for public hospitals. However, the COVID-19 pandemic slowed its development. In 2022, implementation was resumed. After evaluating the program, it was evident that the hospital clusters that had been predefined for differentiated payment did not successfully differentiate homogeneous groups. In 2023, the program was reformed, financing was increased, a single cluster and base rate were defined, and greater hospital complexity was recognized, compared to previous years. Three hospitals were added to the program, for a total of 68. Conclusions. This experience shows that it is possible to sustain a public health financing policy that achieves greater efficiency and equity in the health system, based on the existence of robust institutions that continuously develop and improve.

RESUMO Objetivo. Analisar a implementação de grupos de diagnósticos relacionados (DRG, na sigla em inglês) no Chile, com o objetivo de otimizar a distribuição de recursos públicos. Método. Foi utilizada uma análise narrativa cronológica dos principais marcos, complementada por simulações da implementação de DRG usando concorrência simulada (yardstick competition) e análise de agrupamento para fins de avaliação. Resultados. O modelo de DRG foi introduzido no Chile em 2001, em um contexto acadêmico. Em 2015, o Fundo Nacional de Saúde (FONASA) começou a utilizá-lo no setor privado e, com um projeto-piloto, no setor público. Após quase duas décadas de progresso, em 2020, o programa de DRG foi implementado como mecanismo de pagamento do FONASA para os hospitais públicos. No entanto, a pandemia de COVID-19 interrompeu seu desenvolvimento. Em 2022, a aplicação foi retomada e, após uma avaliação do programa, ficou claro que os grupos hospitalares predefinidos para o pagamento diferenciado por DRG não formavam grupos homogêneos. Em 2023, o programa foi reformulado, com aumento dos recursos financeiros e a definição de um único agrupamento e de uma taxa básica, reconhecendo-se uma maior complexidade hospitalar do que nos anos anteriores. Além disso, três hospitais foram adicionados ao programa, elevando o total para 68. Conclusões. A experiência mostra que é possível dar continuidade a uma política pública de financiamento da saúde para alcançar maior eficiência e equidade no sistema de saúde com base na existência de instituições sólidas que persistam em seu desenvolvimento e contínuo aprimoramento.

Apoyo social percibido en pacientes con Hipertensión Arterial y Diabetes Mellitus tipo II en Atención Primaria y su relación con autopercepción de salud / Social support, self-rated health, treatment adherence and effectiveness in patients with type II diabetes and hypertension

Background: A high level of social support (SS) is associated with better health outcomes in many conditions, such as chronic diseases. Aim : To describe the level of SS in patients with Hypertension and type II Diabetes at Primary Health Care level in Chile and its association with self-rated health, adherence to treatment and better glycemic and blood pressure control. Material and Methods : SS was measured using a social support inventory previously validated in Chile. Self-Rated Health was assessed with a single non-comparative general question; adherence to medication was assessed using the four-item Morisky medication adherence scale. Blood glucose and blood pressure control were also assessed. A logistic regression was performed to estimate Prevalence Odds Ratio (POR) and Robust Poisson method to estimate the Prevalence Ratio (PR). Results : Eighty three percent of the 647 participants evaluated high for SS. There was a significant correlation between SS and Self-rated health (POR 2.32; 95% confidence intervals (CI) 1.19-11.23; PR 1.18; 95% CI 1.07-1.31). No statistically significant association was observed with medication adherence, glycemic or blood pressure control. Conclusions: High levels of SS were found. The association between self-rated health suggests that SS interventions targeting vulnerable subgroups would be worthwhile.

Efectividad de un modelo de manejo de pacientes con hipertensión y diabetes tipo II en atención primaria / Effectiveness of a case management intervention for high blood pressure and type II diabetes in primary health care

Background: Adequate management of high blood pressure (HBP) and Type 2 Diabetes (DM2) is a challenge to the healthcare system in Chile. Aim: To evaluate the effectiveness of a case management (CM) approach to manage HBP and DMII at Primary Healthcare (PHC) level, headed by healthcare technicians with the supervision of registered nurses. Material and Methods: Two primary health care centers were selected. In one the case management approach was used and the other continued with the usual care model. Patients with HBP or DM2 were selected to participate in both centers. The main outcomes were changes blood pressure and glycosylated hemoglobin levels. Results: Three hundred twenty-eight patients were allocated to the intervention group and 316 to control group. At the baseline evaluation, participants at the control health center had better systolic and diastolic BP levels (SBP and DBP), but no difference in glycosylated hemoglobin. After twelve months the adjusted mean difference in HBP patients for SBP was −0.93 (95% conficence intervals (CI) −5.49,3.63) and for DBP was 1.78 (95%CI −2.89,6.43). Among HBP+DMII patients, the mean difference for SBP was −0.51 (95% −0.52,0.49) and for DBP was −3.39 (95%CI −6.07, −0.7). No differences in glycosylated hemoglobin were observed. In a secondary analysis, the intervention group showed a statistically significant higher SBP and DBP reduction than the control group. Conclusions: The case management approach tested in this study had promissory results among patients with high blood pressure.

A snapshot of cancer in Chile: analytical frameworks for developing a cancer policy

INTRODUCTION: The South American country Chile now boasts a life expectancy of over 80 years. As a consequence, Chile now faces the increasing social and economic burden of cancer and must implement political policy to deliver equitable cancer care. Hindering the development of a national cancer policy is the lack of comprehensive analysis of cancer infrastructure and economic impact. OBJECTIVES: Evaluate existing cancer policy, the extent of national investigation and the socio-economic impact of cancer to deliver guidelines for the framing of an equitable national cancer policy. METHODS: Burden, research and care-policy systems were assessed by triangulating objective system metrics -epidemiological, economic, etc. - with political and policy analysis. Analysis of the literature and governmental databases was performed. The oncology community was interviewed and surveyed. RESULTS: Chile utilizes 1% of its gross domestic product on cancer care and treatment. We estimate that the economic impact as measured in Disability Adjusted Life Years to be US$ 3.5 billion. Persistent inequalities still occur in cancer distribution and treatment. A high quality cancer research community is expanding, however, insufficient funding is directed towards disproportionally prevalent stomach, lung and gallbladder cancers. CONCLUSIONS: Chile has a rapidly ageing population wherein 40% smoke, 67% are overweight and 18% abuse alcohol, and thus the corresponding burden of cancer will have a negative impact on an affordable health care system. We conclude that the Chilean government must develop a national cancer strategy, which the authors outline herein and believe is essential to permit equitable cancer care for the country.

Metodología para la evaluación de la relación costo-efectividad en centros de atención primaria de Chile / Methodology for evaluating cost-effectiveness in primary health care centers in Chile

OBJETIVO: Presentar una metodología para la evaluación de la relación costo-efectividad en centros de atención primaria de salud (APS) a partir del modelo de atención familiar promovido en Chile y evaluar los resultados de los dos primeros años de funcionamiento del primer centro piloto que funciona bajo este nuevo modelo de atención primaria. MÉTODOS. Se realizó un estudio de costo-efectividad, con una perspectiva social y un horizonte temporal de un año. Para comparar el centro intervenido (universitario) con el centro de control (municipal) se construyó el índice compuesto de calidad de los centros de salud familiar (ICCESFAM), que combina indicadores técnicos y la percepción de los usuarios de los centros en seis dimensiones: accesibilidad, continuidad de la atención médica, enfoque clínico preventivo y promocional, resolutividad, participación, y enfoque biopsicosocial y familiar. Para calcular los costos se tomó en cuenta el gasto en los centros, el ahorro producido al resto del sistema sanitario y el gasto de bolsillo de los pacientes. Se estimó la razón costo-efectividad incremental (RCEI) y se realizó un análisis de sensibilidad. RESULTADOS: El centro de salud universitario resultó 13,4 por ciento más caro (US$ 8,93 anuales adicionales por inscrito) y más efectivo (ICCESFAM 13,3 por ciento mayor) que el municipal. Estos resultados hacen que la RCEI sea de US$ 0,67 por cada punto porcentual adicional que aumenta el ICCESFAM. CONCLUSIONES: Según el modelo elaborado de evaluación de centros de APS, los centros que siguen el modelo de salud familiar chileno son más efectivos, tanto por sus indicadores técnicos como por la valoración de sus usuarios, que los centros de APS tradicionales.

OBJECTIVE: Present a methodology for evaluating cost-effectiveness in primary health care centers (PHCs) in Chile based on the family health care model promoted in Chile and evaluate the results of the first two years of operation of the first pilot center to work under this new primary-care model. METHODS: A cost-effectiveness study with a social perspective and a one-year time frame was conducted. In order to compare the university health center in question with the control (a municipal health center), a Family Health Center Composite Quality Index (FHCCQI) was devised. It combines technical indicators and user perceptions of the health centers in six areas: access, continuity of medical care, a preventive and promotional clinical approach, problem-solving capability, participation, and a biopsychosocial and family approach. In order to calculate the costs, the centers' expenses, the savings realized in the rest of the health system, and patients' out-of-pocket expenditures were considered. The incremental cost-effectiveness ratio (ICR) was estimated and a sensitivity analysis was performed. RESULTS: The university health center was 13.4 percent more expensive (an additional US$ 8.93 per annum per enrollee) and was more effective (FHCCQI 13.3 percent greater) than the municipal one. Accordingly, the ICR is US$ 0.67 for each additional percentage point of FHCCQI increase. CONCLUSIONS: According to the PHC evaluation model that was implemented, the centers that follow the Chilean family health care model are more effective than traditional PHC centers, as measured by both technical indicators and user ratings.